2020
DOI: 10.1016/j.athoracsur.2019.04.104
|View full text |Cite
|
Sign up to set email alerts
|

Right Anterior Minithoracotomy for Endocarditis After Transcatheter Aortic Valve Replacement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 7 publications
0
6
0
Order By: Relevance
“…In the study presented by Zubarevich et al , all patients underwent SU-AVR via median sternotomy, but minimally invasive cardiac surgery (MICS), which avoids median sternotomy, might be a better way to achieve less invasive surgery. Successful treatment MICS AVR via an upper partial sternotomy has already been reported by Liu et al ( 3 ), and the same procedure via right anterior minithoracotomy has been reported by Zhigalov et al ( 4 ).…”
mentioning
confidence: 61%
“…In the study presented by Zubarevich et al , all patients underwent SU-AVR via median sternotomy, but minimally invasive cardiac surgery (MICS), which avoids median sternotomy, might be a better way to achieve less invasive surgery. Successful treatment MICS AVR via an upper partial sternotomy has already been reported by Liu et al ( 3 ), and the same procedure via right anterior minithoracotomy has been reported by Zhigalov et al ( 4 ).…”
mentioning
confidence: 61%
“…Previous groups have described patients with TAVR-PVE in which bioprosthetic valves were implanted after explantation of the infected prosthesis. 3 , 4 However, conventional bioprostheses and xenografts pose risk of reinfection due to the polyethylene terephthalate and other prosthetic material in them, which is best avoided in PVE. 2 We are the first to report the successful use of an aortic homograft to surgically manage TAVR-PVE.…”
Section: Discussionmentioning
confidence: 99%
“…We have read with great interest the case-report by Zhigalov and colleagues [1]. They presented a 75years-old patient treated for a prosthetic valve endocarditis after TAVR (TAVR-PVE).…”
Section: To the Editormentioning
confidence: 99%